Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes

European Journal of Clinical Investigation

Volumn 43, Issue 5, 2013, Pages 429-438

  Boddi, Maria ^a   Tarquini, Roberto ^a   Chiostri, Marco ^a   Marra, Fabio ^a   Valente, Serafina ^b   Giglioli, Cristina ^b   Gensini, Gian F ^b,c   Abbate, Rosanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Azienda Ospedaliero Universitaria Careggi   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Acute coronary syndromes; Metabolic syndrome; Non alcoholic fatty liver disease; Ultrasound

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; REGRESSION ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; WAIST CIRCUMFERENCE;

ACUTE CORONARY SYNDROME; AGED; CORONARY ARTERY DISEASE; FATTY LIVER; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84876464236     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12065     Document Type: Article

References (37)

1. Loria P, Adinolfi LE, Bellentani S, Bugianesi E, Grieco A, Fargion S et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010;42:272-82.
2. Perseghin G. The role of non-alcoholic fatty liver disease in cardiovascular disease. Dig Dis 2010;28:210-3.
3. Tarquini R, Lazzeri C, Boddi M, Marra F, Abbate R, Gensini GF. Non-alcoholic fatty liver disease: a new challenge for cardiologists. G Ital Cardiol 2010;11:660-9.
4. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341-50.
5. Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008;49:600-7.
6. Treeprasertsuk S, Lopez-Jimenez F, Lindor KD. Nonalcoholic fatty liver disease and the coronary artery disease. Dig Dis Sci 2011;56:35-45.
7. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-73.
8. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113-21.
9. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009;7:234-8.
10. Assy N, Djibre A, Farah R, Grosovski M, Marmor A. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 2010;254:393-400.
11. Alper AT, Hasdemir H, Sahin S, Ontürk E, Akyol A, Nurkalem Z et al. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome. Turk Kardiyol Dern Ars 2008;36:376-81.
12. Bathia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J 2012;33:1190-2000.
13. Wong VW, Wong GL, Yip GW, Lo AO, Limquiaco J, Chu WC et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 2011;60:1721-7.
14. Sun L, Lü SZ. Association between non-alcoholic fatty liver disease and coronary artery disease severity. Chin Med J (Engl) 2011;124:867-72.
15. Arslan U, Türkoglu S, Balcioglu S, Tavil Y, Karakan T, Cengel A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis 2007;18:433-6.
16. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American Optimal medical therapy with or without PCI for stable coronary disease. College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
17. Buiatti E, Barchielli A, Marchionni N, Balzi D, Carrabba N, Valente S et al. Determinants of treatment strategies and survival in acute myocardial infarction: a population-based study in the Florence district, Italy: results of the acute myocardial infarction Florence registry (AMI-Florence). Eur Heart J 2003;24:1195-2203.
18. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-16.
19. Cigolini M, Targher G, Agostino G, Tonoli M, Muggeo M, De Sandre G. Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men-role of the metabolic syndrome. Thromb Haemost 1996;76:69-73.
20. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005-23.
21. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
22. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-62.
23. Targher G, Bertolini L, Rodella S et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring) 2008;16:1394-413.
24. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007;13:1579-84.
25. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007;102:2708-15.
26. Bedogni G, Kahn HS, Bellentani S, Tiribelli C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol 2010;10:98.
27. Needleman L, Kurtz AB, Rifkin MD, Cooper HS, Pasto ME, Goldberg BB. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. Am J Roentgenol 1986;146:1011-5.
28. Boddi M, Abbate R, Chellini B, Giusti B, Giannini C, Pratesi G et al. Hepatitis C virus RNA localization in human carotid plaques. J Clin Virol 2010;47:72-5.
29. Bernetti M, Abbate R, Cerini G, Gensini GF, Poggesi L, Boddi M. Carotid and femoral intima-media thickness as an early atherosclerotic marker. Advantages and limits. G Ital Cardiol (Rome) 2011;12:72-81.
30. Farrell GC, van Rooyen D, Gan L, Chitturi S. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 2012;6:149-71.
31. Day CP. From fat to inflammation. Gastroenterology 2006;130:207-10.
32. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132:2169-80.
33. Tilg H, Moschen AR. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab 2008;19:371-9.
34. Targher G, Chonchol M, Miele L, Zoppini G, Pichiri I, Muggeo M. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. Semin Thromb Hemost 2009;35:277-87.
35. Prasad SB, Fahrtash F, Malaiapan Y, Meredith IT, Cameron J. Obesity and the metabolic syndrome in patients with acute myocardial infarction. Int J Cardiol 2010;144:450-1.
36. Kechagias S, Ernersson A, Dahlqvist O, Lundberg P, Lindström T, Nystrom FH et al. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut 2008;57:649-54.
37. Browning JD, Weis B, Davis J, Satapati S, Merritt M, Malloy CR et al. A low-carbohydrate diet rapidly and dramatically reduces intrahepatic triglyceride content. Hepatology 2008;48:1487-96.